Opportunity Information: Apply for RFA DA 24 017
The National Institutes of Health (NIH) is offering a small business grant opportunity focused on making substance use disorder (SUD) diagnosis and treatment easier to access in real-world settings, especially for people who are currently underserved. The funding opportunity is titled "Field-Deployable, Low-Cost Point-of-Need Approaches and Technologies to Lower the Barriers to Substance Use Disorders (SUD) Diagnosis and Treatment (R41/R42 Clinical Trial Optional)" and is listed under Funding Opportunity Number RFA-DA-24-017. It uses the SBIR-style R41/R42 grant mechanism, which is designed to help small businesses move innovations from early feasibility work into more advanced development and commercialization steps, with clinical trials allowed but not required.
At its core, this FOA is trying to push practical, cost-effective technologies that can reduce or even eliminate disparities in SUD care. The program explicitly calls out three major sources of disparity it wants applicants to tackle: limited geographic access (including the rural vs. urban divide), high treatment costs, and stigma that prevents people from seeking or staying in care. The guiding idea is to flip the usual access model by bringing care to the patient rather than forcing the patient to travel, navigate complex systems, or put themselves in situations that feel unsafe or judgmental. In practice, that means the NIH is looking for approaches that work where people already are, such as in community settings, primary care, mobile units, shelters, workplaces, justice-related settings, or at home, rather than relying only on specialized clinics.
The emphasis on "field-deployable" and "point-of-need" signals that proposed solutions should be designed for use outside of highly controlled, resource-rich environments. Technologies should ideally be low-cost, easy to use, and scalable, with minimal infrastructure requirements and a clear path to reaching people who face barriers like transportation challenges, limited broadband or health system availability, or concerns about privacy and stigma. While the FOA language is broad, it is clearly oriented toward tools or methods that can expand screening, diagnosis, initiation of treatment, monitoring, engagement, adherence support, or other steps in the SUD care continuum in a way that is realistic for day-to-day settings.
Eligibility is limited to small businesses, consistent with the R41/R42 structure. Foreign institutions are not eligible to apply, and non-U.S. components of U.S. organizations are also not eligible. However, the notice indicates that "foreign components" may be allowed under NIH policy definitions, meaning certain discrete parts of a project may be conducted abroad if they meet NIH requirements and are justified, but the applicant organization itself must be eligible and based in the U.S. Applicants are expected to consult the full FOA and NIH Grants Policy Statement definitions to understand what is and is not permitted in terms of international involvement.
From an administrative standpoint, this is a discretionary grant program in the education and health funding activity category, with CFDA number 93.279. The opportunity was created on 2023-05-23 and had an original closing date of 2023-11-09. The listed award ceiling is $295,924, which indicates the maximum award amount expected per award (as presented in the source data). The listing also notes "ExpectedAwards:" but does not provide a number in the provided source, so the precise expected award count is not specified here.
Overall, this grant opportunity is aimed at small businesses that can build and validate affordable, deployable technologies that lower real-life barriers to SUD diagnosis and treatment. Competitive projects will align tightly with the FOA's equity and access goals by demonstrating how their technology reduces distance and access constraints, lowers cost burdens, and/or meaningfully reduces stigma-related barriers, while being usable at the point where help is needed rather than only in traditional treatment settings.Apply for RFA DA 24 017
- The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Field-Deployable, Low-Cost Point-of-Need Approaches and Technologies to Lower the Barriers to Substance Use Disorders (SUD) Diagnosis and Treatment (R41/R42 Clinical Trial Optional)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.279.
- This funding opportunity was created on 2023-05-23.
- Applicants must submit their applications by 2023-11-09. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $295,924.00 in funding.
- Eligible applicants include: Small businesses.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same category: Education, Health
Next opportunity: Advancing Cancer Control Equity Research Through Transformative Solutions (U19 Clinical Trial Optional)
Previous opportunity: Emergency Medicine Research Career Development Program in the Neurological Sciences (EMRCDP-NS) (K12 - No Independent Clinical Trial Allowed)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA DA 24 017
Applicants also applied for:
Applicants who have applied for this opportunity (RFA DA 24 017) also looked into and applied for these:
| Funding Opportunity |
|---|
| Accelerating Behavioral and Social Science through Ontology Development and Use: Research Network Projects (U01 Clinical Trial Not Allowed) Apply for PAR 23 182 Funding Number: PAR 23 182 Agency: National Institutes of Health Category: Education, Health Funding Amount: $500,000 |
| Limited Competition: Cooperative Human Tissue Network (CHTN; UM1 Clinical Trial Not Allowed) Apply for RFA CA 23 024 Funding Number: RFA CA 23 024 Agency: National Institutes of Health Category: Education, Health Funding Amount: $800,000 |
| Investigator-Initiated Research in Genomics and Health Equity (R01 Clinical Trial Optional) Apply for RFA HG 23 017 Funding Number: RFA HG 23 017 Agency: National Institutes of Health Category: Education, Health Funding Amount: $500,000 |
| Leveraging Social Networks to Promote Widespread Individual Behavior Change (R01 Clinical Trial Optional) Apply for RFA AG 24 025 Funding Number: RFA AG 24 025 Agency: National Institutes of Health Category: Education, Health Funding Amount: $500,000 |
| Leveraging Social Networks to Promote Widespread Individual Behavior Change (R34 Clinical Trial Optional) Apply for RFA AG 24 026 Funding Number: RFA AG 24 026 Agency: National Institutes of Health Category: Education, Health Funding Amount: $225,000 |
| NIH Neuroscience Development for Advancing the Careers of a Diverse Research Workforce (R25 Clinical Trial Not Allowed) Apply for PAR 23 178 Funding Number: PAR 23 178 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Substance Use/Substance Use Disorder Dissertation Research Award (R36 Clinical Trials Not Allowed) Apply for PAR 23 194 Funding Number: PAR 23 194 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| The Blood and Marrow Transplant Clinical Trials Network - Data Coordinating Center (U24 Clinical Trial Not Allowed) Apply for RFA HL 24 011 Funding Number: RFA HL 24 011 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| The Blood and Marrow Transplant Clinical Trials Network - Core Clinical Centers (UG1 Clinical Trial Optional) Apply for RFA HL 24 010 Funding Number: RFA HL 24 010 Agency: National Institutes of Health Category: Education, Health Funding Amount: $150,000 |
| Advancing Cancer Control Equity Research through Transformative Solutions Coordination Center (U24 Clinical Trial Optional) Apply for RFA CA 23 027 Funding Number: RFA CA 23 027 Agency: National Institutes of Health Category: Education, Health Funding Amount: $500,000 |
| Advancing Cancer Control Equity Research Through Transformative Solutions (U19 Clinical Trial Optional) Apply for RFA CA 23 026 Funding Number: RFA CA 23 026 Agency: National Institutes of Health Category: Education, Health Funding Amount: $1,500,000 |
| Limited Competition: NIH-DoD-VA Pain Management Collaboratory - Coordinating Center (U24 Clinical Trial Not Allowed) Apply for RFA AT 24 002 Funding Number: RFA AT 24 002 Agency: National Institutes of Health Category: Education, Health Funding Amount: $1,300,000 |
| ADVANCE Predoctoral T32 Training Program to Promote Diversity in Health Disparities Research, Preventive Interventions, and Methodology (T32, Clinical Trial Not Allowed) Apply for RFA OD 23 018 Funding Number: RFA OD 23 018 Agency: National Institutes of Health Category: Education, Health Funding Amount: $300,000 |
| PHS 2023-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required) Apply for PA 23 231 Funding Number: PA 23 231 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Next Generation Chemistry Centers for Fusion Oncoproteins (UM1 Clinical Trial Not Allowed) Apply for RFA CA 23 037 Funding Number: RFA CA 23 037 Agency: National Institutes of Health Category: Education, Health Funding Amount: $1,500,000 |
| Mechanisms of Fusion-Driven Oncogenesis in Childhood Cancers (U01 Clinical Trial Not Allowed) Apply for RFA CA 23 036 Funding Number: RFA CA 23 036 Agency: National Institutes of Health Category: Education, Health Funding Amount: $325,000 |
| NIH-DoD-VA Pain Management Collaboratory ? Pragmatic and/or Implementation Science Demonstration Projects ((UG3/UH3) Clinical Trial Required) Apply for RFA AT 24 004 Funding Number: RFA AT 24 004 Agency: National Institutes of Health Category: Education, Health Funding Amount: $500,000 |
| Microglial Pathophysiology in Comorbid Substance Use Disorder (SUD) and HIV (R61/R33 Clinical Trial Not Allowed) Apply for RFA DA 25 014 Funding Number: RFA DA 25 014 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Innovative Research in Cancer Nanotechnology (IRCN; R01 Clinical Trial Not Allowed) Apply for PAR 23 246 Funding Number: PAR 23 246 Agency: National Institutes of Health Category: Education, Health Funding Amount: $475,000 |
| Ending the Epidemic: New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R34 Clinical Trial optional) Apply for RFA DA 25 020 Funding Number: RFA DA 25 020 Agency: National Institutes of Health Category: Education, Health Funding Amount: $450,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA DA 24 017", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.